Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells.

TitleGroup 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells.
Publication TypeJournal Article
Year of Publication2024
AuthorsTroch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, Guerra GM, Durek P, Tizian C, Sterczyk N, Helfrich S, Duerr CU, Voehringer D, Witkowski M, Artis D, Rollenske T, Kruglov AA, Mashreghi M-F, Klose CSN
JournalNat Commun
Volume15
Issue1
Pagination10566
Date Published2024 Dec 04
ISSN2041-1723
KeywordsAnimals, B-Lymphocytes, Immunity, Innate, Interleukin-1 Receptor-Like 1 Protein, Interleukin-33, Interleukin-5, Lymphocytes, Mice, Mice, Inbred C57BL, Mice, Knockout
Abstract

Tissue-resident immune cells, such as innate lymphoid cells, mediate protective or detrimental immune responses at barrier surfaces. Upon activation by stromal or epithelial cell-derived alarmins, group 2 innate lymphoid cells (ILC2s) are a rapid source of type 2 cytokines, such as IL-5. However, due to the overlap in effector functions, it remains unresolved whether ILC2s are an essential component of the type 2 response or whether their function can be compensated by other cells, such as T cells. Here we show a non-redundant role of ILC2s in supporting the development and function of B1 cells. We demonstrate that B1 cells fail to develop properly in the absence of ILC2s and identify the IL-33 receptor on ILC2s as an essential cell-intrinsic regulator of IL-5 production. Further, conditional deletion of Il5 in ILC2s results in defective B1 cell development and immunoglobulin production. Consequently, B1 cells with phosphatidylcholine specific B cell receptor rearrangements are diminished in ILC2-deficient mice. Thus, our data establish an essential function of ILC2s in supporting B1 cells and antibody production at barrier surfaces.

DOI10.1038/s41467-024-54780-3
Alternate JournalNat Commun
PubMed ID39632879
PubMed Central IDPMC11618303
Grant ListR01 AR070116 / AR / NIAMS NIH HHS / United States
R21 AI142213 / AI / NIAID NIH HHS / United States
R01 AI095466 / AI / NIAID NIH HHS / United States
R01 DK132244 / DK / NIDDK NIH HHS / United States
R01 DK126871 / DK / NIDDK NIH HHS / United States
R01 AI172027 / AI / NIAID NIH HHS / United States
U01 AI095608 / AI / NIAID NIH HHS / United States
375876048 / / Deutsche Forschungsgemeinschaft (German Research Foundation) /
R01 AI151599 / AI / NIAID NIH HHS / United States